康柏西普治疗非缺血型视网膜分支静脉阻塞继发黄斑水肿被引量：9

下载PDF

导出

摘要视网膜静脉阻塞(retinal vein occlusion,RVO)可分为视网膜分支静脉阻塞(BRVO)和视网膜中央静脉阻塞(CRVO),可继发黄斑水肿和黄斑区缺血,是引起视力下降的主要原因[1]。有研究表明RVO患者视网膜血管中生成的血管内皮生长因子(VEGF)持续释放入玻璃体腔,是形成黄斑水肿的关键调控因素[1]。

作者张凌陈彬宾莉陈晓莉乐原陈静

机构地区四川省乐山市人民医院眼科

出处《山西医药杂志》 CAS 2019年第7期787-789,共3页 Shanxi Medical Journal

基金四川省卫生和计划生育委员会科研项目(16PJ160)

关键词视网膜分支静脉阻塞黄斑水肿缺血型继发视网膜中央静脉阻塞血管内皮生长因子视网膜静脉阻塞治疗

分类号 R779.6 [医药卫生—眼科]

引文网络
相关文献

参考文献5

1夏松,陈有信.视网膜静脉阻塞继发黄斑水肿的抗VEGF药物治疗进展[J].眼科新进展,2016,36(11):1093-1096. 被引量：32
2毛剑波,褚梦琪,陈亦棋,郑斌,张赟,沈丽君.玻璃体腔注射康柏西普治疗视网膜静脉阻塞黄斑水肿短期疗效观察[J].中华眼底病杂志,2016,32(4):372-376. 被引量：28
3张菁,蔡小军,陈晓敏,郑恬,郭别川,韩芳芳,王越,柯敏.玻璃体腔注射康柏西普联合视网膜激光光凝治疗视网膜分支静脉阻塞继发黄斑水肿疗效观察[J].中华眼底病杂志,2015,31(1):22-26. 被引量：121
4傅维娜,陈梅珠,王云鹏.Lucentis联合视网膜光凝治疗视网膜分支静脉阻塞继发黄斑水肿[J].眼科新进展,2015,35(3):270-273. 被引量：4
5连海燕,宋艳萍,丁琴,陈中山.康柏西普与雷珠单抗玻璃体腔注射治疗视网膜中央静脉阻塞黄斑水肿短期疗效对比观察[J].中华眼底病杂志,2016,32(4):367-371. 被引量：47

二级参考文献91

1喻晓兵,戴虹,龙力.玻璃体腔曲安奈德注射联合黄斑格栅样光凝治疗糖尿病性弥漫性黄斑水肿[J].中国实用眼科杂志,2007,25(10):1088-1089. 被引量：10
2Pitcher JD 3rd,Liu T,Prasad PS,et al.Short-duration focal pattern grid photocoagulation for macular edema secondary to branch retinal vein occlusion[J].Semin Ophthalmol,2012,27(3-4):69-72.
3Finkelstein D.Argon laser photocoagulation for macular edema in branch vein occlusion[J].Ophthalmology,1986,93(7):975-977.
4Noma H,Funatsu H,Yamasaki M,et al.Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6[J].Am J Ophthalmol,2005,140(2):256-261.
5Hirashima T,Chihara T,Bun T,et al.Intravitreal bevacizumab alone or combined with macular laser photcoagulation for recurrent or persistent macular edema secondary to branch retinal vein occlusion[J/OL].J Ophthalmol,2014,2014:173084[2014-07-07].http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC4119681/pdf/JOPH2014-173084.pdf.
6Tan MH,McAllister IL,Gillies ME,et al.Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion[J].Am J Ophthalmol,2014,157(1):237-247.
7Chen CH,Chen YH,Wu PC,et al.Treatment of branch retinal vein occlusion induced macular edema in treatment-nmve cases with a single intravitreal triamcinolone or bevacizumab injection[J].Chang Gung Med J,2010,33(4):424-435.
8Feng J,Zhao T,Zhang Y,et al.Differences in aqueous concentrations of cytokines in macular edema secondary to branch and central retinal vein occlusion[J/OL].PLoS One,2013,8(7):E68149[2013-07-05].http://www.ncbi.nlm.nih.gov/pmc/articles /PMC3702559/ pdf/pone.0068149.pdf.
9Yoshimura T,Sonoda KH,Sugahara M,et al.Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases[J/OL].Plos One,2009,4(12):8158[2009-12-09].http://www.ncbi.nlm.nih.gov/pmc/articles /PMC2780733 / pdf/pone.0008158.pdf.
10Pfister M,Rothweiler F,Michaelis M,et al.Correlation of inflammatory and proangiogenic cytokines from undiluted vitreous samples with spectral domain OCT scans,in untreated branch retinal vein occlusion[J].Clin Ophthalmol,2013,7:1061-1067.